Intended for healthcare professionals

  1. Research
  2. Use of fenofibrate on...
  3. Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study
CCBYNC Open access
Research

Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study

BMJ 2019; 366 doi: https://doi.org/10.1136/bmj.l5125 (Published 27 September 2019) Cite this as: BMJ 2019;366:l5125

Data supplement

  • Web extra

    • Data Supplement - Supplementary material: additional figure and tables 1-4

Related articles

See more

Cited by...

  • Methodological Challenges using Routine Clinical Care Data for Real-World Evidence: a Rapid Review utilizing a systematic literature search and focus group discussion
  • Multi-omics map revealed PPAR{alpha} activation protecting against myocardial ischemia-reperfusion injury by maintaining cardiac metabolic homeostasis
  • Risk of ischaemic stroke in patients with transient global amnesia: a propensity-matched cohort study
  • Fenofibrate Use Is Associated With Lower Mortality and Fewer Cardiovascular Events in Patients With Diabetes: Results of 10,114 Patients From the Korean National Health Insurance Service Cohort
  • PPARA Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-Lipid
Back to top